病例报告:阿尔法-1抗素治疗的自我管理:两例病例报告
Ana M Escribano Dueñas1, Mónica Martín García2, Begoña Tortajada Goitia3
1Pulmonology Department, Hospital Universitario Costa del Sol, Marbella, Spain.
Frontiers in pharmacology
|December 11, 2023
概括
针对α-1抗素缺乏症 (AATD) 的自我管理增强疗法为诊所访问提供了一种方便的替代方案. 这种方法保持了临床稳定性和患者满意度,而不会影响安全性.
科学领域:
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔法-1抗素缺乏症 (AATD) 是一种遗传性疾病,通常导致肺部疾病.
- 用人类α-1蛋白酶抑制剂进行静脉增强疗法是非吸烟者或前吸烟者AATD患者的标准治疗方法.
- 目前的治疗方案通常涉及每周一次的医院或诊所管理,导致患者日常生活受到重大干扰.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.


